Verastem (VSTM) Misses Q2 EPS by 26c

Verastem (NASDAQ: VSTM) reported Q2 EPS of ($1.06), $0.26 worse than the analyst estimate of ($0.80).

For earnings history and earnings-related data on Verastem (VSTM) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
• Verastem reports 86% six-month survival rate in pancreatic cancer trial